Cargando…
Sclerostin Depletion Induces Inflammation in the Bone Marrow of Mice
Romosozumab, a humanized monoclonal antibody specific for sclerostin (SOST), has been approved for treatment of postmenopausal women with osteoporosis at a high risk for fracture. Previous work in sclerostin global knockout (Sost(−/−)) mice indicated alterations in immune cell development in the bon...
Autores principales: | Donham, Cristine, Chicana, Betsabel, Robling, Alexander G., Mohamed, Asmaa, Elizaldi, Sonny, Chi, Michael, Freeman, Brian, Millan, Alberto, Murugesh, Deepa K., Hum, Nicholas R., Sebastian, Aimy, Loots, Gabriela G., Manilay, Jennifer O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431516/ https://www.ncbi.nlm.nih.gov/pubmed/34502021 http://dx.doi.org/10.3390/ijms22179111 |
Ejemplares similares
-
SOST/Sclerostin Improves Posttraumatic Osteoarthritis and Inhibits MMP2/3 Expression After Injury
por: Chang, Jiun C, et al.
Publicado: (2018) -
Wnt co-receptors Lrp5 and Lrp6 differentially mediate Wnt3a signaling in osteoblasts
por: Sebastian, Aimy, et al.
Publicado: (2017) -
Deletion of Vhl in Dmp1-Expressing Cells Causes Microenvironmental Impairment of B Cell Lymphopoiesis
por: Chicana, Betsabel, et al.
Publicado: (2022) -
Preexisting Type 1 Diabetes Mellitus Blunts the Development of Posttraumatic Osteoarthritis
por: Rios‐Arce, Naiomy D, et al.
Publicado: (2022) -
Single-Cell RNA-Seq Reveals Transcriptomic Heterogeneity and Post-Traumatic Osteoarthritis-Associated Early Molecular Changes in Mouse Articular Chondrocytes
por: Sebastian, Aimy, et al.
Publicado: (2021)